BHC
Bausch Health Companies Inc
NYSE: BHC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.72
+2.33% today
Updated 2026-04-30
Market cap
$2.09B
P/E ratio
13.31
P/S ratio
0.20x
EPS (TTM)
$0.42
Dividend yield
—
52W range
$4 – $9
Volume
1.9M
Bausch Health Companies Inc (BHC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
1.53%
Operating margin
25.80%
ROE
43.60%
ROA
5.18%
Debt/equity
-38.28x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $1.07B | $210.00M | 79.14% | 42.44% | 19.62% |
| 2007 | $842.82M | $195.54M | 73.46% | 22.31% | 23.20% |
| 2008 | $757.18M | $199.90M | 73.96% | 25.90% | 26.40% |
| 2009 | $820.43M | $176.46M | 60.38% | 22.08% | 21.51% |
| 2010 | $1.15B | $-208.19M | 64.60% | -9.60% | -18.16% |
| 2011 | $2.46B | $159.56M | 70.50% | 21.32% | 6.48% |
| 2012 | $3.48B | $-116.03M | 74.40% | 2.29% | -3.33% |
| 2013 | $5.77B | $-866.14M | 73.49% | -7.10% | -15.02% |
| 2014 | $8.20B | $881.00M | 73.13% | 24.40% | 10.74% |
| 2015 | $10.44B | $-268.66M | 76.58% | 14.62% | -2.57% |
| 2016 | $9.67B | $-2.41B | 73.40% | -5.85% | -24.90% |
| 2017 | $8.72B | $2.40B | 70.79% | 1.17% | 27.56% |
| 2018 | $8.38B | $-4.15B | 71.95% | -28.45% | -49.50% |
| 2019 | $8.60B | $-1.78B | 72.68% | -2.36% | -20.73% |
| 2020 | $8.03B | $-559.00M | 71.98% | 8.42% | -6.96% |
| 2021 | $8.43B | $-948.00M | 71.61% | 5.34% | -11.24% |
| 2022 | $8.12B | $-225.00M | 70.90% | 5.59% | -2.77% |
| 2023 | $8.76B | $-592.00M | 70.78% | 11.00% | -6.76% |
| 2024 | $9.63B | $-46.00M | 71.10% | 16.06% | -0.48% |
| 2025 | $10.31B | $155.28M | 68.33% | 20.07% | 1.51% |